SCPHARMACEUTICALS INC. - COMMON STOCK

scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023

01 ноя 2023 15:05:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

31 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives

19 сен 2023 07:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

05 сен 2023 07:00:01 Источник Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

10 авг 2023 15:01:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Announce Second Quarter 2023 Financial Results on Thursday, August 10, 2023

03 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion

01 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

19 июл 2023 07:00:01 Источник Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Addition to Russell 2000® and Russell 3000® Indexes

23 июн 2023 07:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Jefferies Healthcare Conference

31 май 2023 07:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports First Quarter 2023 Financial Results and Provides Business Update

10 май 2023 15:01:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Announce First Quarter 2023 Financial Results on Wednesday, May 10, 2023

02 май 2023 07:00:01 Источник Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update

22 мар 2023 15:05:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2022 Financial Results on Wednesday, March 22

15 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Participate in the Cowen 43rd Annual Health Care Conference

23 фев 2023 07:00:02 Источник Nasdaq GlobeNewswire

scPharmaceuticals Announces Launch and Commercial Availability of FUROSCIX® (furosemide injection)

21 фев 2023 07:00:02 Источник Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 фев 2023 07:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Participate in the SVB Securities Global Biopharma Conference

31 янв 2023 07:00:01 Источник Nasdaq GlobeNewswire

scPharmaceuticals Provides FUROSCIX® (furosemide injection) Commercial Update

30 янв 2023 07:00:01 Источник Nasdaq GlobeNewswire